Guidelines for the treatment of skin and mucosal lesions in Behçet's disease: A secondary publication

Members of the Consensus Conference on Treatment of Skin and Mucosal Lesions (Committee of Guideline for the Diagnosis and Treatment of Mucocutaneous Lesions of Behçet's disease)

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


In the current study, we present guidelines for the diagnosis and treatment of the mucocutaneous lesions of Behçet's disease, which is a chronic inflammatory disease characterized by the involvement of various organs, including mucocutaneous, ocular, vascular, intestinal and central nervous system lesions. It is often identified in the Middle East Mediterranean to East Asia region. Skin manifestations include erythema nodosum, papulopustular lesions and thrombophlebitis, and mucosal manifestations include oral and genital ulcers. These mucocutaneous lesions are characteristically the first signs of Behçet's disease and are important to be recognized for the early diagnosis of the disease. Moreover, these manifestations also recur and persist over the long-term course of the disease. The management of mucocutaneous lesions is important to prevent recurrence. We developed consensus guidelines that provide recommendations for general practitioners and dermatologists and physicians on the management of the mucocutaneous lesions of Behçet's disease.

Original languageEnglish
Pages (from-to)223-235
Number of pages13
JournalJournal of Dermatology
Issue number3
Publication statusPublished - 01-03-2020

All Science Journal Classification (ASJC) codes

  • Dermatology


Dive into the research topics of 'Guidelines for the treatment of skin and mucosal lesions in Behçet's disease: A secondary publication'. Together they form a unique fingerprint.

Cite this